Key player · Company profile
Merck KGaA
Named as a key player in 165 of our reports, across 33 regions and countries.
Named as a key player in 165 of our reports, across 33 regions and countries.
Australia 5
Brazil 5
Canada 5
China 5
Ecuador 5
Egypt 5
France 5
Germany 5
Hong Kong 5
India 5
Italy 5
Japan 5
Kenya 5
Malaysia 5
Mexico 5
New Zealand 5
Philippines 5
Russia 5
Saudi Arabia 5
Singapore 5
South Africa 5
Spain 5
Thailand 5
UAE 5
UK 5
US 5| Market | Category | World 2023 | CAGR |
|---|---|---|---|
| Fertility Service | Healthcare Services | $21 Bn | 6.1% |
| Alopecia areata | Healthcare Services | – | – |
| Anti-Nerve Growth Factor | Pharmaceuticals | – | – |
| Antimicrobial Susceptibility Testing | Healthcare Services | – | – |
| Biological Safety Testing | Pharmaceuticals | – | – |
Named as key players in the same markets as Merck KGaA (number of shared markets).
Pfizer Inc.2 shared markets
Sanofi2 shared markets
Teva Pharmaceutical Industries Ltd.2 shared markets
Thermo Fisher Scientific Inc.2 shared markets
Abbott1 shared market
AbbVie Inc.1 shared market
Accelerate Diagnostics, Inc.1 shared market
Alifax S.r.l.1 shared market